Beclometasona/ formoterol/ bromur de glicopirroni per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
Abstract
Beclometasone / formoterol / glycopyrromine bromide (BECLO / FOR / GLIC) is a combination of fixed doses (CDF) of an inhaled corticosteroid (CI), a long beta-2-adrenergic agonist duration (LABA) and a long-term muscarinic antagonist (LAMA). It is indicated in the maintenance treatment of patients with moderate to severe chronic obstructive pulmonary disease (COPD) that are not adequately controlled with the combination of a CI and a LABA or with the combination of a LABA and a LAMA. However, their funding is restricted to patients already treated with triple therapy that respond
Suitable for drugs on separate devices.
Keywords
Obstructive pulmonary disease; Glycopyrronium bromide; Adult patients
Bibliographic citation
Programa d'Harmonització Farmacoterapèutica. Beclometasona/ formoterol/ bromur de glicopirroni per al tractament de manteniment de la malaltia pulmonar obstructiva crònica. Barcelona: Servei Català de la Salut; 2019.
Audience
Professionals
Use this identifier for quote and/or link this document
https://hdl.handle.net/11351/4074This item appears in following collections
The following license files are associated with this item: